0001209191-20-021848.txt : 20200331
0001209191-20-021848.hdr.sgml : 20200331
20200331170108
ACCESSION NUMBER: 0001209191-20-021848
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200330
FILED AS OF DATE: 20200331
DATE AS OF CHANGE: 20200331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MOZE BARRY
CENTRAL INDEX KEY: 0001619500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35238
FILM NUMBER: 20762581
MAIL ADDRESS:
STREET 1: C/O HORIZON PHARMA, INC.
STREET 2: 520 EAST COOK ROAD, SUITE 520
CITY: DEERFIELD
STATE: IL
ZIP: 60015
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co
CENTRAL INDEX KEY: 0001492426
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
BUSINESS PHONE: 011-353-1-772-2100
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE, 1ST FLOOR
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN
STATE: L2
ZIP: 4
FORMER COMPANY:
FORMER CONFORMED NAME: Horizon Pharma plc
DATE OF NAME CHANGE: 20140919
FORMER COMPANY:
FORMER CONFORMED NAME: HORIZON PHARMA, INC.
DATE OF NAME CHANGE: 20100520
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-03-30
0
0001492426
Horizon Therapeutics Public Ltd Co
HZNP
0001619500
MOZE BARRY
C/O HORIZON THERAPEUTICS PLC
CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD
DUBLIN
L2
4
IRELAND
0
1
0
0
EVP, Chief Admin. Officer
Ordinary Shares
2020-03-30
4
M
0
2106
12.94
A
168397
D
Ordinary Shares
2020-03-30
4
S
0
2106
28.18
D
166291
D
Stock Option (Right to Buy)
12.94
2020-03-30
4
M
0
2106
0.00
D
2020-06-15
Ordinary Shares
2106
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020.
The option is fully vested and exercisable.
/s/ Miles W. McHugh, Attorney-in-Fact
2020-03-31